Accelerate Diagnostics, Inc. vs DermTech, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Accelerate Diagnostics, Inc. is the larger company by market value: $58 M against $52 M for DermTech, Inc., 1.1 times as much (market caps of Jan 5, 2024). Accelerate Diagnostics, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet. DermTech, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Accelerate Diagnostics, Inc. had more revenue: $12 M in the year to December 2024 against $6 M for DermTech, Inc. in the year to December 2020.
- Both made a net loss: $50 M for Accelerate Diagnostics, Inc. and $35 M for DermTech, Inc.
- Accelerate Diagnostics, Inc. keeps more of each dollar of sales: a net margin of -427.7% against -606.9% for DermTech, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Accelerate Diagnostics, Inc. AXDX | DermTech, Inc. DMTK |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1987 | 1995 |
| Size | ||
| Revenue | $12 M | $6 M |
| Net income | $-50 M | $-35 M▲ best |
| Employees | 275 | — |
| Profitability | ||
| Gross margin | 23.1% | — |
| Operating margin | -301.8% | — |
| Net margin | -427.7% | — |
| Growth | ||
| Revenue growth | -3.0% | — |
| Revenue growth, 3 years a year | -0.2% | — |
| Cash | ||
| Free cash flow margin | -211.1% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2024; ratios FY2024 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Accelerate Diagnostics, Inc. or DermTech, Inc.?
Accelerate Diagnostics, Inc. is the larger company by market value: $58 M against $52 M for DermTech, Inc., 1.1 times as much (market caps of Jan 5, 2024). Accelerate Diagnostics, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet. DermTech, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Accelerate Diagnostics, Inc. or DermTech, Inc.?
Accelerate Diagnostics, Inc. had more revenue: $12 M in the year to December 2024 against $6 M for DermTech, Inc. in the year to December 2020. Both made a net loss: $50 M for Accelerate Diagnostics, Inc. and $35 M for DermTech, Inc.
Which is more profitable, Accelerate Diagnostics, Inc. or DermTech, Inc.?
Accelerate Diagnostics, Inc. keeps more of each dollar of sales: a net margin of -427.7% against -606.9% for DermTech, Inc.
More about Accelerate Diagnostics, Inc.
More about DermTech, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.